Type I interferon signals in macrophages and dendritic cells control dengue virus infection: Implications for a new mouse model to test dengue vaccines

Roland Züst, Ying Xiu Toh, Iris Valdés, Daniela Cerny, Julia Heinrich, Lisset Hermida, Ernesto Marcos, Gerardo Guillén, Ulrich Kalinke, Pei-Yong Shi, Katja Fink

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Dengue virus (DENV) infects an estimated 400 million people every year, causing prolonged morbidity and sometimes mortality. Development of an effective vaccine has been hampered by the lack of appropriate small animal models; mice are naturally not susceptible to DENV and only become infected if highly immunocompromised. Mouse models lacking both type I and type II interferon (IFN) receptors (AG129 mice) or the type I IFN receptor (IFNAR-/- mice) are susceptible to infection with mouseadapted DENV strains but are severely impaired in mounting functional immune responses to the virus and thus are of limited use for study. Here we used conditional deletion of the type IIFN receptor (IFNAR) on individual immune cell subtypes to generate a minimally manipulated mouse model that is susceptible to DENV while retaining global immune competence. Mice lacking IFNAR expression on CD11c+ dendritic cells and LysM+ macrophages succumbed completely to DENV infection, while mice deficient in the receptor on either CD11c+ or LysM+ cells were susceptible to infection but often resolved viremia and recovered fully from infection. Conditional IFNAR mice responded with a swift and strong CD8+ T-cell response to viral infection, compared to a weak response in IFNAR-/- mice. Furthermore, mice lacking IFNAR on either CD11c+ or LysM+ cells were also sufficiently immunocompetent to raise a protective immune response to a candidate subunit vaccine against DENV-2. These data demonstrate that mice with conditional deficiencies in expression of the IFNAR represent improved models for the study of DENV immunology and screening of vaccine candidates.

Original languageEnglish (US)
Pages (from-to)7276-7285
Number of pages10
JournalJournal of Virology
Volume88
Issue number13
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Dengue Vaccines
Dengue virus
Interferon Type I
Dengue Virus
dengue
Virus Diseases
interferons
dendritic cells
Dendritic Cells
macrophages
animal models
Macrophages
vaccines
mice
infection
testing
receptors
Interferon alpha-beta Receptor
biological resistance
immune response

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Medicine(all)

Cite this

Type I interferon signals in macrophages and dendritic cells control dengue virus infection : Implications for a new mouse model to test dengue vaccines. / Züst, Roland; Toh, Ying Xiu; Valdés, Iris; Cerny, Daniela; Heinrich, Julia; Hermida, Lisset; Marcos, Ernesto; Guillén, Gerardo; Kalinke, Ulrich; Shi, Pei-Yong; Fink, Katja.

In: Journal of Virology, Vol. 88, No. 13, 2014, p. 7276-7285.

Research output: Contribution to journalArticle

Züst, R, Toh, YX, Valdés, I, Cerny, D, Heinrich, J, Hermida, L, Marcos, E, Guillén, G, Kalinke, U, Shi, P-Y & Fink, K 2014, 'Type I interferon signals in macrophages and dendritic cells control dengue virus infection: Implications for a new mouse model to test dengue vaccines', Journal of Virology, vol. 88, no. 13, pp. 7276-7285. https://doi.org/10.1128/JVI.03827-13
Züst, Roland ; Toh, Ying Xiu ; Valdés, Iris ; Cerny, Daniela ; Heinrich, Julia ; Hermida, Lisset ; Marcos, Ernesto ; Guillén, Gerardo ; Kalinke, Ulrich ; Shi, Pei-Yong ; Fink, Katja. / Type I interferon signals in macrophages and dendritic cells control dengue virus infection : Implications for a new mouse model to test dengue vaccines. In: Journal of Virology. 2014 ; Vol. 88, No. 13. pp. 7276-7285.
@article{9f6cd4bba24c427a9f8b1b6de74fd6ec,
title = "Type I interferon signals in macrophages and dendritic cells control dengue virus infection: Implications for a new mouse model to test dengue vaccines",
abstract = "Dengue virus (DENV) infects an estimated 400 million people every year, causing prolonged morbidity and sometimes mortality. Development of an effective vaccine has been hampered by the lack of appropriate small animal models; mice are naturally not susceptible to DENV and only become infected if highly immunocompromised. Mouse models lacking both type I and type II interferon (IFN) receptors (AG129 mice) or the type I IFN receptor (IFNAR-/- mice) are susceptible to infection with mouseadapted DENV strains but are severely impaired in mounting functional immune responses to the virus and thus are of limited use for study. Here we used conditional deletion of the type IIFN receptor (IFNAR) on individual immune cell subtypes to generate a minimally manipulated mouse model that is susceptible to DENV while retaining global immune competence. Mice lacking IFNAR expression on CD11c+ dendritic cells and LysM+ macrophages succumbed completely to DENV infection, while mice deficient in the receptor on either CD11c+ or LysM+ cells were susceptible to infection but often resolved viremia and recovered fully from infection. Conditional IFNAR mice responded with a swift and strong CD8+ T-cell response to viral infection, compared to a weak response in IFNAR-/- mice. Furthermore, mice lacking IFNAR on either CD11c+ or LysM+ cells were also sufficiently immunocompetent to raise a protective immune response to a candidate subunit vaccine against DENV-2. These data demonstrate that mice with conditional deficiencies in expression of the IFNAR represent improved models for the study of DENV immunology and screening of vaccine candidates.",
author = "Roland Z{\"u}st and Toh, {Ying Xiu} and Iris Vald{\'e}s and Daniela Cerny and Julia Heinrich and Lisset Hermida and Ernesto Marcos and Gerardo Guill{\'e}n and Ulrich Kalinke and Pei-Yong Shi and Katja Fink",
year = "2014",
doi = "10.1128/JVI.03827-13",
language = "English (US)",
volume = "88",
pages = "7276--7285",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "13",

}

TY - JOUR

T1 - Type I interferon signals in macrophages and dendritic cells control dengue virus infection

T2 - Implications for a new mouse model to test dengue vaccines

AU - Züst, Roland

AU - Toh, Ying Xiu

AU - Valdés, Iris

AU - Cerny, Daniela

AU - Heinrich, Julia

AU - Hermida, Lisset

AU - Marcos, Ernesto

AU - Guillén, Gerardo

AU - Kalinke, Ulrich

AU - Shi, Pei-Yong

AU - Fink, Katja

PY - 2014

Y1 - 2014

N2 - Dengue virus (DENV) infects an estimated 400 million people every year, causing prolonged morbidity and sometimes mortality. Development of an effective vaccine has been hampered by the lack of appropriate small animal models; mice are naturally not susceptible to DENV and only become infected if highly immunocompromised. Mouse models lacking both type I and type II interferon (IFN) receptors (AG129 mice) or the type I IFN receptor (IFNAR-/- mice) are susceptible to infection with mouseadapted DENV strains but are severely impaired in mounting functional immune responses to the virus and thus are of limited use for study. Here we used conditional deletion of the type IIFN receptor (IFNAR) on individual immune cell subtypes to generate a minimally manipulated mouse model that is susceptible to DENV while retaining global immune competence. Mice lacking IFNAR expression on CD11c+ dendritic cells and LysM+ macrophages succumbed completely to DENV infection, while mice deficient in the receptor on either CD11c+ or LysM+ cells were susceptible to infection but often resolved viremia and recovered fully from infection. Conditional IFNAR mice responded with a swift and strong CD8+ T-cell response to viral infection, compared to a weak response in IFNAR-/- mice. Furthermore, mice lacking IFNAR on either CD11c+ or LysM+ cells were also sufficiently immunocompetent to raise a protective immune response to a candidate subunit vaccine against DENV-2. These data demonstrate that mice with conditional deficiencies in expression of the IFNAR represent improved models for the study of DENV immunology and screening of vaccine candidates.

AB - Dengue virus (DENV) infects an estimated 400 million people every year, causing prolonged morbidity and sometimes mortality. Development of an effective vaccine has been hampered by the lack of appropriate small animal models; mice are naturally not susceptible to DENV and only become infected if highly immunocompromised. Mouse models lacking both type I and type II interferon (IFN) receptors (AG129 mice) or the type I IFN receptor (IFNAR-/- mice) are susceptible to infection with mouseadapted DENV strains but are severely impaired in mounting functional immune responses to the virus and thus are of limited use for study. Here we used conditional deletion of the type IIFN receptor (IFNAR) on individual immune cell subtypes to generate a minimally manipulated mouse model that is susceptible to DENV while retaining global immune competence. Mice lacking IFNAR expression on CD11c+ dendritic cells and LysM+ macrophages succumbed completely to DENV infection, while mice deficient in the receptor on either CD11c+ or LysM+ cells were susceptible to infection but often resolved viremia and recovered fully from infection. Conditional IFNAR mice responded with a swift and strong CD8+ T-cell response to viral infection, compared to a weak response in IFNAR-/- mice. Furthermore, mice lacking IFNAR on either CD11c+ or LysM+ cells were also sufficiently immunocompetent to raise a protective immune response to a candidate subunit vaccine against DENV-2. These data demonstrate that mice with conditional deficiencies in expression of the IFNAR represent improved models for the study of DENV immunology and screening of vaccine candidates.

UR - http://www.scopus.com/inward/record.url?scp=84901981496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901981496&partnerID=8YFLogxK

U2 - 10.1128/JVI.03827-13

DO - 10.1128/JVI.03827-13

M3 - Article

C2 - 24741106

AN - SCOPUS:84901981496

VL - 88

SP - 7276

EP - 7285

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 13

ER -